Thyroid C-cell Tumors: In rodent scientific tests, semaglutide is shown to result in thyroid C-cell tumors. It can be unfamiliar regardless of whether this risk applies to individuals, but semaglutide is contraindicated in people with a private or household history of medullary thyroid carcinoma (MTC) or individuals with Several Endocrine Neoplasia